In the US, it is unlikely to achieve collective immunity to the coronavirus

This is due to many infection variants and a high proportion of those who do not want to be vaccinated, experts interviewed by NYT noted.

Collective immunity to the coronavirus is unlikely to be formed in the United States due to many infection variants and the high proportion of those who do not want to be vaccinated. The New York Times, citing expert assessments, reported this on Monday.

With reference to its calculations, the publication notes that at least 30% of Americans doubt the need for vaccination. At the same time, the newspaper points out, for the formation of collective immunity to the British version of the coronavirus, the presence of antibodies in 80% of the population is required.

However, as The New York Times notes, such calculations are relative because, firstly, the United States is not isolated from other countries of the world. For a complete victory over the pandemic, a high level of immunity is necessary for all humanity. Secondly, the high average level of immunity does not reflect the real state of affairs in various parts of a large country like the United States, where in one city, the number of people who have antibodies due to vaccination or after an illness can be significantly higher than in another, where people for some reason massively refuse to be vaccinated.

“Collective immunity has only confused people, who have come to believe that we will never defeat the infection if we do not achieve this mystical indicator,” the newspaper quotes the director of the National Institute of Allergic and Infectious Diseases of the United States, Anthony Fauci. “So we stopped using the term in the classical sense and just say: if you vaccinate enough people, we will defeat the infection.” The New York Times notes that as a result, the coronavirus will probably never completely disappear and will become a seasonal disease, outbreaks of which will periodically occur in certain regions of the country. The challenge is to develop effective measures to treat the disease and prevent many victims during such outbreaks.

Author: Steve Cowan
Graduated From Princeton University. He has been at the Free Press since October 2014. Previously worked as a regional entertainment editor.
Function: Chief-Editor